SARS_CoV_2 mutation literature information.


  Clinical outcomes in COVID-19 patients infected with different SARS-CoV-2 variants in Marseille, France.
 PMID: 34044152       2021       Clinical microbiology and infection
Result: In addition, lower rate of rhinitis was observed in M4V infection as compared to 20AS and a higher hospitalisation rate was associated with M4V infection as compared to M1V.
Discussion: The severity is also different since the M1V was less severe than other lineages, the N501YV appears to be less severe than the M4V, which seems to have had the
Discussion: This underlines the fact that COVID-19 presents a variability from July 2020, which is associated with epidemiological modifications such as the source (the M1V undoubtedly came from Africa, the 20AS from China, the N501YV from England and the source of M4V is unknown but is believed to be of European origin).



Browser Board

 Co-occurred Entities




   Filtrator